Doctrack Solutions Submits Share Capital Audit Report for Sep'26 Quarter
Docmode Health Technologies Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 9:28 pm
Doctrack Solutions Submits Share Capital Audit Report for Sep'26 Quarter Doctrack Solutions Limited submitted its Reconciliation of Share Capital Audit Report under Regulation 76 of SEBI Regulations for the quarter ended 30th Sep'26. The company鈥檚 total issued and listed capital on the NSE Emerge platform stands at 31,42,800 equity shares (face value Rs. 10 each). The shareholding is 100% dematerialized, with CDSL holding 20,44,937 shares (65%) and NSDL holding 10,97,863 shares (35%). The auditor confirmed no changes in share capital, no pending demat requests over 21 days, and full reconciliation across registers.
Original exchange filing (PDF)
More announcements from Docmode Health Technologies Ltd
- DHTL: Docmode Health Technologies Limited has submitted to the Exchange, the Financial Results along with Statement on Impact of Audit Qualifications Report for the period ended March 31, 2026'. 路 19 Oct 2026
- Ramesh kumar jain and Ramesh Jain HUF has Submitted to the Exchange a copy of Disclosure under Regulation 29 (2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. 路 06 Oct 2026
- Docmode Health Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 05 Oct 2026
- Docmode Health Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 路 30 Sept 2026
- Docmode Health Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026 路 08 Sept 2026
- Docmode Health Technologies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 路 05 Sept 2026
- Doctrack Solutions Limited has informed the Exchange about Board Meeting to be held on 04-Sep-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended March 2026 . 路 04 Sept 2026
- To consider and approve Audited Standalone and Consolidated Financial Results for the half year and financial year ended on 31st March, 2026. 路 30 Mar 2026
